Piramal Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Jun '24
Mar '24
Dec '23
Sep '23
Jun '23
Total Qtr Revenue cr
1,970.68
2,578.74
2,020.08
1,960.57
1,787.16
Other Income Qtr Cr19.5426.3861.5149.1938.31
Operating Revenues Qtr1,951.142,552.361,958.571,911.381,748.85

*All values are in Cr.

Operating Expenses Qtr
1,746.65
2,022.43
1,690.20
1,645.74
1,616.53
Operating Profit Qtr
204.49
529.93
268.37
265.64
132.32
EBIDT Qtr Cr
224.03
525.79
297.61
314.83
170.63
Depreciation Qtr
184.55
196.13
186.32
184.51
173.61
Net Profit Qtr
-88.64
101.27
10.11
5.02
-98.58
Basic EPS Qtr
-0.67
0.77
0.08
0.04
-0.83
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -